Open AccessProstate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
Author(s) -
Zhaoqiang Dong,
Yuzhen Wang,
Jing Guo,
Chuan Tian,
Wengu Pan,
Hongwei Wang,
Jieke Yan
Publication year - 2022
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s366622
Subject(s) - in vivo , chemistry , docetaxel , epidermal growth factor receptor , cancer research , hyaluronic acid , formononetin , cancer cell , cancer , biophysics , pharmacology , receptor , biochemistry , medicine , biology , daidzein , microbiology and biotechnology , anatomy , genistein
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom